Local resident among those who benefited from monoclonal antibodies treatment for COVID-19
November 18, 2021
WORLAND – An emergency use authorization treatment for COVID-19 proved beneficial for one local resident.
When the COVID-19 pandemic first began in the spring of 2020, no specific treatment for the virus existed. Since then, however, the Food and Drug Association (FDA) has granted Emergency Use Authorization (EUA) to several monoclonal antibody therapies as treatments for COVID-19.
For access to this article please sign in or subscribe.